Dr. Elitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
517 S Euclid Ave
Fl 1
Saint Louis, MO 63110Phone+1 314-362-3431Fax+1 314-362-6564
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 2021 - 2024- Washington University/B-JH/SLCH ConsortiumInternship, Preliminary Year, 2020 - 2021
Case Western Reserve University School of MedicineClass of 2020, MD, PhD
Certifications & Licensure
MO State Medical License 2020 - 2026
Awards, Honors, & Recognition
- Heed Resident Retreat Society of Heed Fellows, 2024
- Ophthalmology Groundbreakers YoungMD Connect, 2023
- Triple Crown Award St. Louis Children’s Hospital, 2021
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPelizaeus-Merzbacher disease: on the cusp of myelin medicine.Matthew S Elitt, Paul J Tesar
Trends in Molecular Medicine. 2024-05-01 - 8 citationsEnhancers of Human and Rodent Oligodendrocyte Formation Predominantly Induce Cholesterol Precursor Accumulation.Joel L Sax, Samantha N Hershman, Zita Hubler, Dharmaraja Allimuthu, Matthew S Elitt
ACS Chemical Biology. 2022-08-19 - 46 citationsSuppression of proteolipid protein rescues Pelizaeus–Merzbacher diseaseMatthew S. Elitt, Lilianne Barbar, H. Elizabeth Shick, Berit Powers, Yuka Maeno-Hikichi
Nature. 2020-07-01
Press Mentions
Case Western Reserve University-Led Team Develops New Approach to Treat Certain Neurological DiseasesJuly 2nd, 2020
CWRU-led team develops new approach to treat certain neurological diseasesNovember 22nd, 2020
Convelo Therapeutics Enters Worldwide Collaboration with GenentechNovember 22nd, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
